This clinical research study is evaluating an investigational medication, ML-007C-MA, for adults with schizophrenia. The study is designed to assess the long-term safety, tolerability, and effectiveness of the study medication.
Key Eligibility Criteria:
To pre-qualify for this study, an individual must:
- Be 18 to 64 years of age
- Have a primary diagnosis of schizophrenia
- Have an identified reliable informant available to participate in relevant assessments
- Currently in a stable living situation
- Meet additional study criteria
- Some medications may not be allowed during the study. Additional medical and study requirements will be reviewed during screening.
Contact us or fill out the form below so we can reach out to you and move forward with pre-screening questions to assess your overall eligibility.